miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression

RNA-based therapeutics could represent a new avenue of cancer treatment. miRNA 331-3p (miR-331-3p) is implicated in prostate cancer (PCa) as a putative tumor suppressor, but its functional activity and synergy with other anti-tumor agents is largely unknown. We found miR-331-3p expression in PCa tum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Epis, Michael R., Giles, Keith M., Beveridge, Dianne J., Richardson, Kirsty L., Candy, Patrick A., Stuart, Lisa M., Bentel, Jacqueline, Cohen, Ronald J., Leedman, Peter J.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589646/
https://ncbi.nlm.nih.gov/pubmed/28903407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18664
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados